Does RIFABUTIN Cause Agranulocytosis? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Agranulocytosis have been filed in association with RIFABUTIN (Rifabutin). This represents 0.8% of all adverse event reports for RIFABUTIN.
13
Reports of Agranulocytosis with RIFABUTIN
0.8%
of all RIFABUTIN reports
0
Deaths
12
Hospitalizations
How Dangerous Is Agranulocytosis From RIFABUTIN?
Of the 13 reports, 12 (92.3%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for RIFABUTIN.
What Other Side Effects Does RIFABUTIN Cause?
Drug ineffective (171)
Off label use (127)
Drug resistance (123)
Drug interaction (99)
Drug intolerance (97)
Pyrexia (95)
Drug reaction with eosinophilia and systemic symptoms (81)
Nausea (77)
Neutropenia (77)
Mycobacterium avium complex infection (76)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which RIFABUTIN Alternatives Have Lower Agranulocytosis Risk?
RIFABUTIN vs RIFAMPICIN
RIFABUTIN vs RIFAMPIN
RIFABUTIN vs RIFAMYCIN
RIFABUTIN vs RIFAPENTINE
RIFABUTIN vs RIFAXIMIN